Wed, March 7, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
Amylin Pharmaceuticals Announces Public Offering of Common Stock
[ Wed, Mar 07th 2012 ] - Market Wire
Resmed Inc. to Present at Upcoming Conferences
[ Wed, Mar 07th 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Transcend Services, Inc.
[ Wed, Mar 07th 2012 ] - Market Wire
International Drug &;; Explosives Detec .. ounces Strategic Alliance With an American Compan
[ Wed, Mar 07th 2012 ] - Market Wire
SPX-106T Arrests Development of Atherosclerotic Plaques in Mouse Model of Cardiovascular Disease
[ Wed, Mar 07th 2012 ] - Market Wire
Fourteenth Patient Dosed in Neuralstem ALS Stem Cell Trial
[ Wed, Mar 07th 2012 ] - Market Wire
Prana Doses First Patient in the "IMAGINE" Phase II Alzheimer's Disease Trial
[ Wed, Mar 07th 2012 ] - Market Wire
GenVec to Release Fourth Quarter and Year-End 201 .. s and Conduct a Conference Call on March 15, 2012
[ Wed, Mar 07th 2012 ] - Market Wire
EnteroMedics to Present at the 24th Annual ROTH Capital Growth Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Discovery Labs to Hold Conference Call to Discuss FDA Approval of SURFAXIN (lucinactant)
[ Wed, Mar 07th 2012 ] - Market Wire
iBio to Present at the 24th Annual ROTH Conference on March 14
[ Wed, Mar 07th 2012 ] - Market Wire
Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Synthetic Biologics to Present at ROTH Annual Growth Stock Conference
[ Wed, Mar 07th 2012 ] - Market Wire
Transcept Pharmaceuticals to Report Fourth Quarte .. l Results and Host Conference Call on March 14, 2
[ Wed, Mar 07th 2012 ] - Market Wire
Horizon Pharma Enters Into Exclusive Agreement Wi .. ization of LODOTRA(R) (Modified-Release Prednison
[ Wed, Mar 07th 2012 ] - Market Wire
CMS Assigns Payment to Novadaq's SPY Imaging Under OPPS
[ Wed, Mar 07th 2012 ] - Market Wire
Solta Medical Provides Update on Liposonix Launch
[ Wed, Mar 07th 2012 ] - Market Wire
The Ensign Group Acquires an Idaho Skilled Nursing Facility
[ Wed, Mar 07th 2012 ] - Market Wire
OncoSec's OMS ElectroImmunotherapy Technology Pla .. I Merkel Cell Carcinoma Clinical Trial Featured i
[ Wed, Mar 07th 2012 ] - Market Wire
Inovio Appoints Vaccine Industry Leader to its Scientific Advisory Board
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Discovery Labs Announces FDA Approval of SURFAXIN .. ) for Prevention of Respiratory Distress Syndrome
[ Tue, Mar 06th 2012 ] - Market Wire
TPI Updated Corporate Presentation at 32nd Cowen's Healthcare Conference
[ Tue, Mar 06th 2012 ] - Market Wire
PharmAthene to Host Year-End 2011 Earnings Conference Call and Webcast on Thursday, March 8, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
ProMetic Secures a $2.5 Million Follow on Agreement
[ Tue, Mar 06th 2012 ] - Market Wire
Lpath Raises $9.3 Million in Equity Financing
[ Tue, Mar 06th 2012 ] - Market Wire
CareFusion To Acquire Pharmacy Automation Technology Leader
[ Tue, Mar 06th 2012 ] - Market Wire
STATS ChipPAC's Scalable 3D eWLB Solutions Delive .. t Advantages Over Substrate-Based Package-on-Pack
[ Tue, Mar 06th 2012 ] - Market Wire
Idenix Pharmaceuticals Announces Declaration of a Patent Interference by the USPTO
[ Tue, Mar 06th 2012 ] - Market Wire
Comprehensive Care Corporation Expands Contract with Nation's Largest Public Health Plan
[ Tue, Mar 06th 2012 ] - Market Wire
More Regulation Looms for the Medical Equipment and Supplies Industry
[ Tue, Mar 06th 2012 ] - Market Wire
Shares of Antares Pharma and Boston Scientific on .. l Equipment and Supplies Industry Soaring in 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
[ Tue, Mar 06th 2012 ] - Market Wire
Titan Medical Inc. Announces Memorandum of Unders .. with Switzerland Based Clinique Generale-Beaulieu
[ Tue, Mar 06th 2012 ] - Market Wire
InspireMD Announces its 2011 Year End Financial Results
[ Tue, Mar 06th 2012 ] - Market Wire
Cytokinetics Announces That the European Medicine .. 57 Orphan Medicinal Product Designation for the T
[ Tue, Mar 06th 2012 ] - Market Wire
Rigel Announces Fourth Quarter and Year End 2011 Financial Results
[ Tue, Mar 06th 2012 ] - Market Wire
Shire to Initiate Two Phase 4 Clinical Trials to .. mine dimesylate) Capsules, (CII) to Concerta (met
[ Tue, Mar 06th 2012 ] - Market Wire
Implant Sciences Joins SOSSEC - Consortium of Lea .. rs in Security &;; Defense Technologies
[ Tue, Mar 06th 2012 ] - Market Wire
PAREXEL International to Present at Barclays Capital Healthcare Conference
[ Tue, Mar 06th 2012 ] - Market Wire
Threshold Pharmaceuticals Announces Oral Presenta .. 02 Clinical Study at the 2012 AACR Annual Meeting
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Cadence Pharmaceuticals to Host Conference Call a .. Quarter and Full Year 2011 Financial Results on M
[ Mon, Mar 05th 2012 ] - Market Wire
Major Repligen (Nasdaq: RGEN) Shareholder Files Amended 13D
[ Mon, Mar 05th 2012 ] - Market Wire
HealthSouth to Present at the Barclays Capital Global Healthcare Conference
[ Mon, Mar 05th 2012 ] - Market Wire
Gemoscan Canada Announces Appointment of Vice President, Investor Relations
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
Lilly Pledges $100,000 to American Red Cross' Tornado Disaster Relief Efforts
[ Mon, Mar 05th 2012 ] - Market Wire
BIOLASE Declares Stock Dividend for 2012 First Quarter
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
[ Mon, Mar 05th 2012 ] - Market Wire
Access Pharmaceuticals Announces Preliminary Four .. 9; MuGard Product Revenue Increases 400% Quar
[ Mon, Mar 05th 2012 ] - Market Wire
New Stem Cell Research Shows Promising Results -- Advanced Cell Tech and NeoStem Poised to Benefit
[ Mon, Mar 05th 2012 ] - Market Wire
Sequenom Announces Participation at the 24th Annual Roth OC Growth Stock Conference
[ Mon, Mar 05th 2012 ] - Market Wire
Cytokinetics Announces Fundamental Research in th .. le Activation Published in the Journal Nature Med
[ Mon, Mar 05th 2012 ] - Market Wire
BioDelivery Sciences to Present at Cowen and ROTH Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the 24th Annual ROTH Conference
[ Mon, Mar 05th 2012 ] - Market Wire
The Ensign Group Announces Acquisition of Doctors Express Franchise System
[ Mon, Mar 05th 2012 ] - Market Wire
OncoSec to Present at Cowen and ROTH Healthcare Conferences
[ Mon, Mar 05th 2012 ] - Market Wire
BioLife Solutions Commences Build-Out of Second G .. P Production Suite and Corporate Office Expansion
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head amp;; .. ncers Induces Robust T-Cell Immune Response in Mi
[ Mon, Mar 05th 2012 ] - Market Wire
Inovio Therapeutic Vaccine for Head & Neck and Ot .. ers Induces Robust T-Cell Immune Response in Mice
[ Mon, Mar 05th 2012 ] - Market Wire
diaDexus Launches PLAC Test for Lp-PLA(2) Activity in Europe
Fri, March 2, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
Baxter Presents Long-Term Data on HyQ During AAAAI Annual Meeting
[ Fri, Mar 02nd 2012 ] - Market Wire
Baxter Receives Marketing Authorization in Europe .. Union for VEPACEL Pre-Pandemic Influenza Vaccine
[ Fri, Mar 02nd 2012 ] - Market Wire
GTx Announces Webcast of Corporate Presentation at the Cowen and Co. Annual Health Care Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Barclays Capital Global Healthcare Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Boston Therapeutics to Be Quoted as BTHE on the OTC Bulletin Board
[ Fri, Mar 02nd 2012 ] - Market Wire
Alere to Attend the Raymond James amp;; As .. stitutional Investors Conference on March 6, 2012
[ Fri, Mar 02nd 2012 ] - Market Wire
Warnex Extends Maturity Date of its Outstanding D .. entures and Provides Update on its Listing Status
[ Fri, Mar 02nd 2012 ] - Market Wire
Abbott's STARLIMS Business Acquires Distribution Partners to Build International Presence
[ Fri, Mar 02nd 2012 ] - Market Wire
Syneron Closes Acquisition of Ultrashape Ltd.
[ Fri, Mar 02nd 2012 ] - Market Wire
Amerigroup Expands Operations in Texas
[ Fri, Mar 02nd 2012 ] - Market Wire
Arena Pharmaceuticals Files European Marketing Au .. ion Application for Lorcaserin for Weight Control
[ Fri, Mar 02nd 2012 ] - Market Wire
Orexigen Therapeutics Schedules March 8, 2012 Web .. Results for the Fourth Quarter and Year Ended Dec
[ Fri, Mar 02nd 2012 ] - Market Wire
ProMetic Announces Changes to Its Board of Directors
[ Fri, Mar 02nd 2012 ] - Market Wire
Given Imaging Supports Fight Against Colorectal Cancer
[ Fri, Mar 02nd 2012 ] - Market Wire
SciClone Announces Results of Interim Analysis of Phase 2 SCV-07 Oral Mucositis Trial
[ Fri, Mar 02nd 2012 ] - Market Wire
Media Advisory - Oncolytics Biotech Inc. to Prese .. en and Company 32nd Annual Health Care Conference
[ Fri, Mar 02nd 2012 ] - Market Wire
Delcath to Conduct Conference Call to Discuss Full Year 2011 Results and Recent Corporate Progress
[ Fri, Mar 02nd 2012 ] - Market Wire
IRIDEX to Present at Upcoming Investment Conferences
[ Fri, Mar 02nd 2012 ] - Market Wire
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
[ Fri, Mar 02nd 2012 ] - Market Wire
Concord Medical to Report Fourth Quarter and Full Year 2011 Financial Results on March 21, 2012
Thu, March 1, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Idenix Pharmaceuticals Elects Thomas Hodgson as C .. Appoints Michael Wyzga to Its Board of Directors
[ Thu, Mar 01st 2012 ] - Market Wire
IMRIS reports fourth quarter and annual 2011 financial results
[ Thu, Mar 01st 2012 ] - Market Wire
Peregrine to Report Third Quarter Fiscal Year 2012 Financial Results After Market on March 9, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Avanir Pharmaceuticals to Participate in Two Conferences in March
[ Thu, Mar 01st 2012 ] - Market Wire
Helix BioPharma Corp. Announces L-DOS47 Scientifi .. the Second Annual IBC Conference on Analytical Te
[ Thu, Mar 01st 2012 ] - Market Wire
Abbott to Build Nutrition Manufacturing Facility in Ohio
[ Thu, Mar 01st 2012 ] - Market Wire
Southern Home Medical Provides Corporate Overview for Shareholders and Financial Industry
[ Thu, Mar 01st 2012 ] - Market Wire
Tibet Pharmaceuticals, Inc. Announces Receipt of .. g Privatequot;; Proposal at $3.00 Per Shar
[ Thu, Mar 01st 2012 ] - Market Wire
Novelos Therapeutics and Academic Collaborators H .. pted for Presentation at 2012 AACR Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Cantel Medical Corp. to Hold Conference Call to D .. lts for Its Second Quarter Ended January 31, 2012
[ Thu, Mar 01st 2012 ] - Market Wire
Boston Scientific Announces Launch of PROMUS Elementa" Platinum Chromium Stent System in Japan
[ Thu, Mar 01st 2012 ] - Market Wire
Revealing an Innovative Corporate Structure Dedicated to Redefining Healthcare Value
[ Thu, Mar 01st 2012 ] - Market Wire
Hamilton Thorne Expands Distribution Partnership .. e and Optical Systems Producer Leica Microsystems
[ Thu, Mar 01st 2012 ] - Market Wire
Peregrine Announces Seven Abstracts Accepted for Presentation at AACR 2012 Annual Meeting
[ Thu, Mar 01st 2012 ] - Market Wire
Amica Mature Lifestyles Increases Ownership in Amica at Dundas
[ Thu, Mar 01st 2012 ] - Market Wire
Trimel Pharmaceuticals Corporation to Report Fina .. 11 and Host a Conference Call to Update Investors
[ Thu, Mar 01st 2012 ] - Market Wire
Digirad Corporation Board of Directors Adopts Strengthened Charter and Policies
[ Thu, Mar 01st 2012 ] - Market Wire
Novadaq Announces NASDAQ Listing
[ Thu, Mar 01st 2012 ] - Market Wire
Omeros to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Thu, Mar 01st 2012 ] - Market Wire
Herborium Group to Begin Commercialization of its .. roducts With Aggressive Plans to Take a Bite of a
Wed, February 29, 2012
[ Wed, Feb 29th 2012 ] - Market Wire
AMI Research Initiates Analyst Coverage on Pressure BioSciences, Inc.;; BUY
[ Wed, Feb 29th 2012 ] - Market Wire
Marshall Edwards CEO to Present at Roth Capital Partners Growth Stock Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Thera Max Cold and Flu Brand Receives Great Benef .. Ongoing Social Media Marketing Awareness Program
[ Wed, Feb 29th 2012 ] - Market Wire
Celsion to Present at Upcoming Investor Conferences in March 2012
[ Wed, Feb 29th 2012 ] - Market Wire
Hi-Tech Pharmacal Receives Final Approval for Levetiracetam Oral Solution
[ Wed, Feb 29th 2012 ] - Market Wire
BioSpecifics Technologies Corp. Announces Present .. ons at Two Upcoming Investor Conferences in March
[ Wed, Feb 29th 2012 ] - Market Wire
Cempra, Inc. to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
Avanir Pharmaceuticals and Concert Pharmaceutical .. to Develop and Commercialize Deuterium-modified D
[ Wed, Feb 29th 2012 ] - Market Wire
AMRI Expands Quality Control Leadership to Support Future Growth
[ Wed, Feb 29th 2012 ] - Market Wire
Mylan Launches First Equivalent Product to Lexapro Tablets
[ Wed, Feb 29th 2012 ] - Market Wire
Synergetics USA Announces Conference Call to Review Second Quarter of Fiscal Year 2012 Results
[ Wed, Feb 29th 2012 ] - Market Wire
Dyax Announces Appointment of Dr. Burt Adelman as Chief Medical Officer
[ Wed, Feb 29th 2012 ] - Market Wire
Horizon Pharma Announces $50.8 Million Private Placement
[ Wed, Feb 29th 2012 ] - Market Wire
Arrowhead Announces Patent Issuance Covering siRNA Inhibitors of HIF-2a (EPAS1)
[ Wed, Feb 29th 2012 ] - Market Wire
BioLineRx Announces Receipt of Notice of Allowanc .. ing BCM (BL-1040), a Novel Medical Device for Pre
[ Wed, Feb 29th 2012 ] - Market Wire
Biogen Idec levert aanvraag in bij FDA voor goedk .. ale BG-12 voor behandeling van Multiple Sclerosis
[ Wed, Feb 29th 2012 ] - Market Wire
Columbia Laboratories Will Present March 5th at Cowen and Company Health Care Conference
[ Wed, Feb 29th 2012 ] - Market Wire
ProMetic Finalizes Its Agreement With Celgene Corporation
[ Wed, Feb 29th 2012 ] - Market Wire
OncoSec's OMS ElectroOncology Technology Platform .. n Medical Device amp;; Diagnostic Industry
[ Wed, Feb 29th 2012 ] - Market Wire
Auxilium Partners With the National Organization for Rare Disorders to Observe Rare Disease Day
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Ironwood Pharmaceuticals Provides Fourth Quarter 2011 Investor Update
[ Tue, Feb 28th 2012 ] - Market Wire
Healthways to Present at the Barclays Capital Global Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Quest Diagnostics to Speak at the 2012 RBC Capital Markets Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Cowen 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson & Johnson to Participate in Cowen and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Johnson amp;; Johnson to Participate in Co .. en and Company 32nd Annual Health Care Conference
[ Tue, Feb 28th 2012 ] - Market Wire
Teva to Present at the 2012 RBC Capital Marketsa Global Healthcare Conference
[ Tue, Feb 28th 2012 ] - Market Wire
AdCare Health Systems to Present at the ROTH Capi .. Partners 24th Annual Conference on March 12, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
AVI BioPharma Announces FDA Approval to Proceed W .. Dosing of AVI-6003 for Treatment of Marburg Virus
[ Tue, Feb 28th 2012 ] - Market Wire
ARIAD Reports 2011 Financial Results and Outlines .. Development and Commercialization Plans for 2012
[ Tue, Feb 28th 2012 ] - Market Wire
POZEN Reports Fourth Quarter & Year End 2011 Results
[ Tue, Feb 28th 2012 ] - Market Wire
UnitedHealthcare to Strengthen Service to Florida .. of Preferred Care Partners and Medica Healthcare
[ Tue, Feb 28th 2012 ] - Market Wire
Aviation Security in China Continues to Purchase .. lant Sciences' Explosives Trace Detection Devices
[ Tue, Feb 28th 2012 ] - Market Wire
BioDelivery Sciences and FDA Reach Agreement on BNX Development Plan
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
[ Tue, Feb 28th 2012 ] - Market Wire
Delcath to Present at 24th Annual Roth Growth Stock Conference on March 12
[ Tue, Feb 28th 2012 ] - Market Wire
OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma
[ Tue, Feb 28th 2012 ] - Market Wire
Astex Pharmaceuticals to Announce 2011 Fourth Qua .. r and Year-End Financial Results on March 5, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Inovio Pharmaceuticals to Present at Cowen and ROTH Investor Conferences
Mon, February 27, 2012
[ Mon, Feb 27th 2012 ] - Market Wire
Forest Laboratories, Inc. and Gedeon Richter Plc. .. ositive Phase III Trials with the Investigational
[ Mon, Feb 27th 2012 ] - Market Wire
BioLineRx Ltd. Announces Closing of $15 Million Private Placement to Institutional Investors
[ Mon, Feb 27th 2012 ] - Market Wire
Cloudant Names Andy Palmer to Its Board of Directors
[ Mon, Feb 27th 2012 ] - Market Wire
BrainStorm'sNurOwna" Stem Cell Technology Offers Hope for Treating Huntington Disease
[ Mon, Feb 27th 2012 ] - Market Wire
Alexion to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Mon, Feb 27th 2012 ] - Market Wire
CEO of Pressure BioSciences Sees Firm's Momentum Continuing to Build in 2012
[ Mon, Feb 27th 2012 ] - Market Wire
OPKO Invests in BioZone Pharmaceuticals, Inc.
[ Mon, Feb 27th 2012 ] - Market Wire
Unigene to Present at IBC's 4th Annual AsiaTIDES Oligonucleotide and Peptide Conference
[ Mon, Feb 27th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Halozyme Therapeutics, Inc. and Masimo Corporation
[ Mon, Feb 27th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Akorn, Inc. and Ironwood Pharmaceuticals, Inc.
[ Mon, Feb 27th 2012 ] - Market Wire
Cancer Therapies From Dendreon and AEterna Zentaris Poised to Boost Profits
[ Mon, Feb 27th 2012 ] - Market Wire
Cancer Treatments Evolve - Exelixis and Seattle Genetics Look to Lead
[ Mon, Feb 27th 2012 ] - Market Wire
St. Jude Medical Announces Increase in Quarterly Dividend
[ Mon, Feb 27th 2012 ] - Market Wire
ARIAD to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Mon, Feb 27th 2012 ] - Market Wire
VentriPoint Completes Validation Study for Pulmonary Arterial Hypertension Application
[ Mon, Feb 27th 2012 ] - Market Wire
Brookdale to Present at 2012 RBC Capital Markets' Healthcare Conference on February 29
[ Mon, Feb 27th 2012 ] - Market Wire
Auxilium Pharmaceuticals to Present at the 2012 Cowen Healthcare Conference
[ Mon, Feb 27th 2012 ] - Market Wire
Delcath Announces First CHEMOSAT Procedures in Germany
[ Mon, Feb 27th 2012 ] - Market Wire
Stereotaxis to Report Fourth Quarter and Full Year 2011 Financial Results on March 5, 2012
[ Mon, Feb 27th 2012 ] - Market Wire
PAREXEL International to Present at Cowen Healthc .. Conference and Raymond James Investors Conference
Sat, February 25, 2012
[ Sat, Feb 25th 2012 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against TranS1 Inc.
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
ZOLL Medical Corporation to Present at the Citi 2 .. rence and the RBC Capital Markets 2012 Healthcare
[ Fri, Feb 24th 2012 ] - Market Wire
Update on Motion for Authorization to Institute Class Action Against the Company
[ Fri, Feb 24th 2012 ] - Market Wire
Aetna Board of Directors Declares Quarterly Cash Dividend, Authorizes Additional Share Repurchases
[ Fri, Feb 24th 2012 ] - Market Wire
Greatbatch, Inc. to Participate in the 2012 RBC Capital Marketsa Healthcare Conference
[ Fri, Feb 24th 2012 ] - Market Wire
Celldex Therapeutics to Present at the Citi 2012 Global Health Care Conference
[ Fri, Feb 24th 2012 ] - Market Wire
Dual Inhibition of MET and VEGF Signaling With Ca .. zantinib Blocks Tumor Invasiveness and Metastasis
[ Fri, Feb 24th 2012 ] - Market Wire
International Drug & Explosives Detection Company .. enta Corp. Announces Orders Since January 1, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
IGSM GROUP INC., Holding Company Completes First Acquisition
[ Fri, Feb 24th 2012 ] - Market Wire
Perception, Opportunity in Volatility - Research .. is on VIVUS, Inc. and Arena Pharmaceuticals, Inc.
[ Fri, Feb 24th 2012 ] - Market Wire
BIOLASE Announces the Introduction of the Waterla .. Lasers at the Chicago Dental Society Midwinter M
[ Fri, Feb 24th 2012 ] - Market Wire
2012 Economic Outlook - Report Highlights Becton, .. on and Co. and Health Management Associates, Inc.
[ Fri, Feb 24th 2012 ] - Market Wire
NxStage Kicks Off Annual Dialysis Conference 2012 .. brity and Former NxStage User Stephen Furst and O
[ Fri, Feb 24th 2012 ] - Market Wire
Titan Medical Inc. Lists on OTCQX Market in the USA
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
[ Fri, Feb 24th 2012 ] - Market Wire
Heska Announces Quarterly Dividend of $0.10 per Share
[ Fri, Feb 24th 2012 ] - Market Wire
HERBORIUM GROUP Announces Signing the Letter of I .. ina Health Resource Inc. for Possible Acquisition
[ Fri, Feb 24th 2012 ] - Market Wire
SANUWAVE Announces Distribution Agreement for Canada
[ Fri, Feb 24th 2012 ] - Market Wire
OncoSec to Present at 10th Annual BioPartnering North America
[ Fri, Feb 24th 2012 ] - Market Wire
Threshold Pharmaceuticals to Present at the Cowen Health Care Conference
[ Fri, Feb 24th 2012 ] - Market Wire
Forest Laboratories Receives European Marketing Approval for Colobreathe Dry Powder Inhaler
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
Vanda Pharmaceuticals to Participate in Upcoming Investor Conferences
[ Thu, Feb 23rd 2012 ] - Market Wire
Brookdale to Present at Citi's 2012 Global Health Care Conference on February 28
[ Thu, Feb 23rd 2012 ] - Market Wire
Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
30 p.m. ET to Discuss Financial Results for the Fourth Quarter and Year Ended 2011
[ Thu, Feb 23rd 2012 ] - Market Wire
Savient Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Idenix Pharmaceuticals Reports Fourth Quarter and .. 11 Financial Results and Provides Pipeline Update
[ Thu, Feb 23rd 2012 ] - Market Wire
Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance
[ Thu, Feb 23rd 2012 ] - Market Wire
YM BioSciences Announces Proposed Public Offering of Common Shares
[ Thu, Feb 23rd 2012 ] - Market Wire
Avid Bioservices to Present at IBC's Antibody Development and Production Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Aetnaas 2012 African American History Calendar Highlights Entrepreneurship in the Community
[ Thu, Feb 23rd 2012 ] - Market Wire
XenoPort to Present at the RBC Capital Markets' Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
National Health Scan Inc. (NHSN) Merger Introduction
[ Thu, Feb 23rd 2012 ] - Market Wire
DURECT to Participate in Upcoming Healthcare Conferences
[ Thu, Feb 23rd 2012 ] - Market Wire
Cigna Corporation Announces Appearance at the Citi 2012 Global Health Care Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Care360 EHR From Quest Diagnostics Honored by Bla .. k Book's 2012 Rankings and Capterra's Top 20 List
[ Thu, Feb 23rd 2012 ] - Market Wire
Theratechnologies to Present at RBC Capital Markets Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Medtronic CFO Gary Ellis to Speak at Citi Healthcare Conference
[ Thu, Feb 23rd 2012 ] - Market Wire
Abbott Collaborates with Leading U.S. Forensics Center on Human Identification Testing

MannKind to Present at Cowen and Company 32nd Annual Health Care Conference


//health-fitness.news-articles.net/content/2012/ .. -company-32nd-annual-health-care-conference.html
Published in Health and Fitness on Wednesday, February 29th 2012 at 14:15 GMT by Market Wire   Print publication without navigation


VALENCIA, Calif.--([ ])--MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Cowen and Company 32nd Annual Health Care Conference on March 7, 2012 at 10:40am Eastern at the Boston Marriott Copley Place in Boston, Massachusetts.

Interested parties can access a link to the live webcast of the presentations from the News & Events section of the Company's website at [ http://www.mannkindcorp.com ].

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product candidate, AFREZZA, is in late stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. MannKind maintains a website at [ www.mannkindcorp.com ] to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.


Publication Contributing Sources